Eton Pharmaceuticals Inc. (ETON) Tops Q3 EPS by 8c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q3 EPS of ($0.02), $0.08 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $7 million versus the consensus estimate of $6.26 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• Moody’s upgrades Brinker to Ba1 on Chili’s growth and debt reduction
• UBS Upgrades Nan Ya Plastics Corp. (1303:TT) to Buy